{"id":870073,"date":"2025-08-04T12:06:05","date_gmt":"2025-08-04T16:06:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/"},"modified":"2025-08-04T12:06:05","modified_gmt":"2025-08-04T16:06:05","slug":"twist-bioscience-announces-fiscal-2025-third-quarter-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/","title":{"rendered":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results<\/b><\/p>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.twistbioscience.com%2F&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=Twist+Bioscience+Corporation&amp;index=1&amp;md5=fb65a6a12db65cfbf83e36fe44f38656\">Twist Bioscience Corporation<\/a> (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025.<\/p>\n<p>\n\u201cA strong balance sheet and disciplined cost-management underpin our focused business execution,\u201d said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience.<\/p>\n<p>\nVisit the Events and Presentations page of the Investor Relations section under the \u201cCompany\u201d tab at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.twistbioscience.com&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=www.twistbioscience.com&amp;index=2&amp;md5=01f6edd52c28976ff0bbbf9462418ace\">www.twistbioscience.com<\/a> to view the <b>detailed fiscal third quarter 2025 earnings report<\/b> and the <b>investor presentation, <\/b>or click<b \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.twistbioscience.com%2Fevents-and-presentations&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.twistbioscience.com%2Fevents-and-presentations&amp;index=3&amp;md5=dd9c0062485a0ec57613e1eb8e31be9f\">https:\/\/investors.twistbioscience.com\/events-and-presentations<\/a>.<\/p>\n<p>\nThe company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss its financial results and provide an update on the company\u2019s business. The conference call will be webcast live through the Investor Relations section under the \u201cCompany\u201d tab at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.twistbioscience.com&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=www.twistbioscience.com&amp;index=4&amp;md5=facc3c73de74147806b5d23c2d9c64e1\">www.twistbioscience.com<\/a>. Those parties interested in participating via telephone must register on the Company\u2019s Investor Relations website or by clicking <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBIcce891b1a0804ced8aa67370a25d918c&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=here&amp;index=5&amp;md5=a8bb17d52d451905f275e3fa6ed5db8d\">here<\/a>. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.<\/p>\n<p><b>About Twist Bioscience Corporation<\/b><\/p>\n<p>\nAt Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and defense, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.<\/p>\n<p>\nOur innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis, sequencing and therapeutics discovery, providing both the quality and quantity of the tools they need to most rapidly realize the opportunity ahead. For more information about our products and services, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.twistbioscience.com&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=www.twistbioscience.com&amp;index=6&amp;md5=da2db9468d177726abeb471f3a31d74a\">www.twistbioscience.com<\/a>.<\/p>\n<p>\nFollow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftwist-bioscience%2F&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=e25080de917003faff89f500cc4b04b4\">LinkedIn<\/a> | <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Ftwistbioscience&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=X&amp;index=8&amp;md5=51ba21f5d066b626b7fd8f3d354d1600\">X<\/a> | <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fc%2FTwistBioscience&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=YouTube&amp;index=9&amp;md5=56976d71552f85b2ad8bf502a9bea909\">YouTube<\/a> | <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Ftwist_bioscience%2F%3Fhl%3Den&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=Instagram&amp;index=10&amp;md5=a5b81dbdc2cd6f8d8957d9fd0c4d9603\">Instagram<\/a> | <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbsky.app%2Fprofile%2Ftwistbioscience.com&amp;esheet=54301926&amp;newsitemid=20250804802153&amp;lan=en-US&amp;anchor=Bluesky&amp;index=11&amp;md5=d802f1155970253f3f01e4646617aa03\">Bluesky<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250804802153\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250804802153\/en\/<\/a><\/span><\/p>\n<p><b>For Investors:<br \/>\n<\/b><br \/>Angela Bitting<br \/>\n<br \/>SVP, Corporate Affairs<br \/>\n<br \/>925-202-6211<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:abitting@twistbioscience.com\">abitting@twistbioscience.com<\/a><\/p>\n<p><b>For Media:<br \/>\n<\/b><br \/>Amanda Houlihan<br \/>\n<br \/>Communications Manager<br \/>\n<br \/>774-265-5334<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ahoulihan@twistbioscience.com\">ahoulihan@twistbioscience.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Science Health Research<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250804802153\/en\/1121919\/3\/Twist_Bioscience_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. \u201cA strong balance sheet and disciplined cost-management underpin our focused business execution,\u201d said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the \u201cCompany\u201d tab at www.twistbioscience.com to view the detailed fiscal third quarter 2025 earnings report and the investor presentation, or clickhttps:\/\/investors.twistbioscience.com\/events-and-presentations. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-870073","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. \u201cA strong balance sheet and disciplined cost-management underpin our focused business execution,\u201d said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the \u201cCompany\u201d tab at www.twistbioscience.com to view the detailed fiscal third quarter 2025 earnings report and the investor presentation, or clickhttps:\/\/investors.twistbioscience.com\/events-and-presentations. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss &hellip; Continue reading &quot;Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T16:06:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results\",\"datePublished\":\"2025-08-04T16:06:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/\"},\"wordCount\":436,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/\",\"name\":\"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-08-04T16:06:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Market Newsdesk","og_description":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211;Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced financial results and business highlights for the third quarter fiscal 2025 ended June 30, 2025. \u201cA strong balance sheet and disciplined cost-management underpin our focused business execution,\u201d said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. Visit the Events and Presentations page of the Investor Relations section under the \u201cCompany\u201d tab at www.twistbioscience.com to view the detailed fiscal third quarter 2025 earnings report and the investor presentation, or clickhttps:\/\/investors.twistbioscience.com\/events-and-presentations. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss &hellip; Continue reading \"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-04T16:06:05+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results","datePublished":"2025-08-04T16:06:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/"},"wordCount":436,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/","name":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-08-04T16:06:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250804802153r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/twist-bioscience-announces-fiscal-2025-third-quarter-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=870073"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/870073\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=870073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=870073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=870073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}